Sign In  |  Register  |  About San Anselmo  |  Contact Us

San Anselmo, CA
September 01, 2020 1:33pm
7-Day Forecast | Traffic

  • Search Hotels in San Anselmo

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Biontech Se ADR (NQ: BNTX )

113.13 +4.90 (+4.53%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Biontech Se ADR

< Previous 1 2
...
24 25 26 27 28 29 30 31 32
...
65 66 Next >
FDA Expert Panel Favors COVID-19 Boosters Targeting Omicron BA.4, BA.5 Subvariants
Via Benzinga
Why BioNTech Stock Is Surging
BioNTech SE (NASDAQ: BNTX) shares are trading higher Thursday after the company and Pfizer Inc (NYSE: PFE) announced a new COVID-19 vaccine supply agreement with the U.S. government. 
Via Benzinga
Why Pfizer Stock Is Rising Today
Pfizer Inc (NYSE: PFE) shares are trading higher Thursday after the company and BioNTech SE (NASDAQ: BNTX) announced a new COVID-19 vaccine supply agreement with the U.S. government. 
Via Benzinga
This Analyst Says US Government Buying More COVID-19 Vaccines At Higher Prices
Via Benzinga
PFE Stock Rises as Pfizer Requests FDA Approval of Covid-19 Treatment Paxlovid
PFE stock is up in afternoon trading as Pfizer enjoys a double round of positive news regarding its Covid-19 drugs. 
Via InvestorPlace
The FDA Just Handed BioNTech And Moderna A Gift — But Only One Jumped
The request is a boon for BioNTech and Moderna, both of which are facing a sales cliff. 
Via Investor's Business Daily
BioNTech Whale Trades Spotted
A whale with a lot of money to spend has taken a noticeably bearish stance on BioNTech. Looking at options history for BioNTech (NASDAQ:BNTX) we detected 14 strange trades. 
Via Benzinga
The Daily Biotech Pulse: Pfizer/BioNTech Ink New COVID-19 Vaccine Supply Pact, Sanofi Hit By FDA Clinical Hold, Angion Biomedica Halts Second Kidney Disease Trial
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Benzinga Before The Bell: Texas Giga Tesla's Output Ramp Up, California's Lithium Tax, Spot Bitcoin ETF Proposal Rejection And Other Top Financial Stories Thursday, June 30
Reuters Hyundai, Affiliates Plan To Set Up New Company In US: 
Via Benzinga
US Government Calls For Additional Doses Of Pfizer/BioNTech COVID-19 Vaccine
Via Benzinga
Pfizer and BioNTech Announce New Agreement with U.S. Government to Provide Additional Doses of COVID-19 Vaccine
From Pfizer Inc.
Via Business Wire
Pfizer, Moderna Analysts Respond To FDA COVID Booster Ruling: 'Revenues Will Decline'
The Food and Drug Administration’s panel of independent vaccine experts recently voted 19 to 2 to recommend a new batch of COVID-19 booster shots targeting the omicron variant this fall. The news,... 
Via Benzinga
Novavax Stock Is in Prime Position For Speculation
NVAX stock is on the cusp of the FDA approval that has long eluded the firm, meaning now is the best time to speculate on Novavax. 
Via InvestorPlace
Pfizer, Moderna, Novavax Tumble As FDA Experts Consider Omicron Shots
A panel of experts will decide whether to recommend omicron-specific boosters. 
Via Investor's Business Daily
US Government Offers $75M Support For Lipid Systems Expansion Used In mRNA COVID-19 Vaccines
Via Benzinga
Why Pfizer Partner BioNTech Shares Are Rising Today
BioNTech SE - ADR (NASDAQ: BNTX) shares are trading higher by 6.31% at $142.50 after the company announced its Omicron-adapted COVID-19 vaccine candidates demonstrated high immune response against the... 
Via Benzinga
The Daily Biotech Pulse: CHMP Backs AstraZeneca's Breast Cancer Therapies, Ipsen Buys Epizyme, FDA Holds For Nuvation Bio, Astellas Studies
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Pfizer/BioNTech's Updated Omicron-Based COVID-19 Shots Show Improved Response Against Variant
Via Benzinga
7 Biotech Stocks With Key Catalysts Coming in July
Biotech stocks have had a rocky few months, but many are on the mend. These picks should provide investors both flexibility and growth. 
Via InvestorPlace
Pfizer and BioNTech Announce Omicron-Adapted COVID-19 Vaccine Candidates Demonstrate High Immune Response Against Omicron
From Pfizer Inc.
Via Business Wire
The Daily Biotech Pulse: European Backing For Novavax's COVID-19 Shot In Adolescents, Sanofi-GSK's Updated Vaccine Effective Against Omicron, FDA's Clinical Hold On Sarepta's Duchenne Trial
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
BioNTech Gets EMA's Priority Medicines Status For Testicular Cancer Drug
BioNTech (NASDAQ: BNTX) received Priority Medicines (PRIME) designation from the European Medicines Agency (EMA) for its product candidate BNT211 in the third- or later-line treatment of testicular... 
Via Benzinga
7 Long-Term Stocks to Buy in a Bear Market
These long-term stocks to buy are from defensive sectors, because now is the time to play defense in your stock investing. 
Via InvestorPlace
Pfizer-BioNTech COVID-19 Vaccine Receives FDA Emergency Use Nod For Kids As Young As Six Months
Via Benzinga
Pfizer, Moderna Snag FDA OK For Covid Shots In Children At 6 Months Old
The decision expands Covid shots out to the last group to become eligible. 
Via Investor's Business Daily
Pfizer-BioNTech COVID-19 Vaccine Receives FDA Emergency Use Authorization for Children 6 Months through 4 Years of Age
From Pfizer Inc.
Via Business Wire
Bavarian Nordic Launches COVID-19 Booster Study To Compare Against Pfizer/BioNTech Shot
Via Benzinga
The Daily Biotech Pulse: Roche's Alzheimer's Drug Fails, Advisors Back Pfizer, Moderna Shots For Youngest Kids, Valneva Settles COVID-19 Pact With UK
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
FDA Committee Backs Pfizer, Moderna COVID-19 Vaccines For Toddlers, Youngest Children
The FDA's Vaccines and Related Biological Products Advisory Committee voted i 
Via Benzinga
As Omicron Surges, FDA Mulls Pfizer, Moderna Covid Shots For Babies
Pfizer studied a three-dose regimen. Moderna looked at two doses. 
Via Investor's Business Daily
< Previous 1 2
...
24 25 26 27 28 29 30 31 32
...
65 66 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SanAnselmo.com & California Media Partners, LLC. All rights reserved.